Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006
The general evaluation of elderly patients with community acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004
The general evaluation of community acquired pneumonia patients treated in our clinic Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004
Clinical presentation and evolution of community acquired pneumonia in older patients Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012
Fusing ICU clinical care and clinical research in severe community acquired pneumonia Source: International Congress 2016 – PG16 Infection control in epidemics: strengthening the evidence base for healthcare workers and the public Year: 2016
Severe community acquired pneumonia: clinical and aetiological evaluation Source: Eur Respir J 2007; 30: Suppl. 51, 673s Year: 2007
Therapeutic regimens in community acquired pneumonia (CAP): association with patients characteristics and outcomes Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008
Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011
Progress of quality indicator rates regarding treatment of patients hospitalized in Germany due to community acquired pneumonia (CAP) Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Effect of a quality improvement plan on the outcome of patients with community acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 545s Year: 2003
An RDW-based clinical model predicts long-term survival in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation multicentric study Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020
Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004
A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia Source: Eur Respir J 2001; 18: 362-368 Year: 2001
Significance of comorbidity in elderly patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 3s Year: 2006
Outcome of community aquired pneumonia in elderly patients Source: Eur Respir J 2006; 28: Suppl. 50, 530s Year: 2006
Contribution of clinical pulmonary infection score in the diagnosis of hospital acquired pneumonia Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011
Clinical management of patients newly diagnosed with COPD through targeted case finding and routine care: a longitudinal analysis of the TargetCOPD trial Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018
Diagnosis and management of community acquired pneumonia in adults Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines Year: 2020
Features of community acquired pneumonia in patients hospitalized in the institute for pulmonary diseases over a five-year period Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006